IMPLICATIONS FOR PATIENT CARE: The results suggest that [212Pb]Pb-DOTAMTATE could potentially offer a more effective targeted α-therapy treatment option for SSTR2-positive NETs with a favorable tumor retention and dosimetry profile. The gene discussed is SSTR2; the disease is neoplasm.